<DOC>
	<DOC>NCT00392262</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of valsartan plus amlodipine in hypertensive patients not responding to treatment with amlodipine or felodipine alone.</brief_summary>
	<brief_title>A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1. Male or female patients (18 years) 2. Patients with moderate essential hypertension (untreated must have MSSBP ≥160 and &lt;180 mmHg at Visit 1, treated must have MSSBP &lt;180 mmHg at Visit 1) (WHO grade II) 1. Severe hypertension(MSDBP ≥110 mmHg or MSSBP ≥ 180 mmHg) 2. Pregnant or nursing women 3. Treated hypertensive patients with controlled hypertension under current therapy (diastolic BP &lt; 90 mmHg and systolic BP &lt; 140 mmHg) 4. A history of cardiovascular disease, including angina pectoris, myocardial infarction, coronary artery bypass graft, percutaneous transluminal coronary angioplasty, transient ischemic attack, stroke, and heart failure NYHA II IV Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Moderate essential hypertension (WHO grade II)</keyword>
</DOC>